Cargando…

Development of the new CPTSD diagnosis for ICD-11

BACKGROUND: The diagnosis of complex post-traumatic stress disorder (CPTSD) was proposed several decades ago by scientist-practitioners, almost parallel to the first description of the diagnosis of post-traumatic stress disorder (PTSD). In the previous International Classification of Diseases, versi...

Descripción completa

Detalles Bibliográficos
Autor principal: Maercker, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919312/
https://www.ncbi.nlm.nih.gov/pubmed/33641675
http://dx.doi.org/10.1186/s40479-021-00148-8
_version_ 1783658113137639424
author Maercker, Andreas
author_facet Maercker, Andreas
author_sort Maercker, Andreas
collection PubMed
description BACKGROUND: The diagnosis of complex post-traumatic stress disorder (CPTSD) was proposed several decades ago by scientist-practitioners, almost parallel to the first description of the diagnosis of post-traumatic stress disorder (PTSD). In the previous International Classification of Diseases, version 10 (ICD-10) issued by the World Health Organization (WHO), this symptom constellation was termed ‘enduring personality change after catastrophic experience’. This diagnosis has not been clinically influential, nor has it been subjected to much research. Thus, in a multi-stage process of ICD-11 development, the diagnosis of CPTSD was developed. METHODS: This paper provides a review of the historical lines of development that led to the CPTSD diagnosis, as well as the results since the ICD-11 publication in 2018. RESULTS: The CPTSD diagnosis comprises the core symptoms of the – newly, narrowly defined – PTSD diagnosis, the three symptom groups of affective, relationship, and self-concept changes. The diagnosis is clinically easy to use in accordance with the WHO development goals for the ICD-11 and has shown good psychodiagnostic properties in various studies, including good discrimination from personality disorder with borderline pattern. CONCLUSION: The scholarly use of the new diagnosis has resulted in an increasing number of published studies on this topic in the diagnostic and therapeutic fields.
format Online
Article
Text
id pubmed-7919312
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79193122021-03-02 Development of the new CPTSD diagnosis for ICD-11 Maercker, Andreas Borderline Personal Disord Emot Dysregul Review BACKGROUND: The diagnosis of complex post-traumatic stress disorder (CPTSD) was proposed several decades ago by scientist-practitioners, almost parallel to the first description of the diagnosis of post-traumatic stress disorder (PTSD). In the previous International Classification of Diseases, version 10 (ICD-10) issued by the World Health Organization (WHO), this symptom constellation was termed ‘enduring personality change after catastrophic experience’. This diagnosis has not been clinically influential, nor has it been subjected to much research. Thus, in a multi-stage process of ICD-11 development, the diagnosis of CPTSD was developed. METHODS: This paper provides a review of the historical lines of development that led to the CPTSD diagnosis, as well as the results since the ICD-11 publication in 2018. RESULTS: The CPTSD diagnosis comprises the core symptoms of the – newly, narrowly defined – PTSD diagnosis, the three symptom groups of affective, relationship, and self-concept changes. The diagnosis is clinically easy to use in accordance with the WHO development goals for the ICD-11 and has shown good psychodiagnostic properties in various studies, including good discrimination from personality disorder with borderline pattern. CONCLUSION: The scholarly use of the new diagnosis has resulted in an increasing number of published studies on this topic in the diagnostic and therapeutic fields. BioMed Central 2021-03-01 /pmc/articles/PMC7919312/ /pubmed/33641675 http://dx.doi.org/10.1186/s40479-021-00148-8 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Maercker, Andreas
Development of the new CPTSD diagnosis for ICD-11
title Development of the new CPTSD diagnosis for ICD-11
title_full Development of the new CPTSD diagnosis for ICD-11
title_fullStr Development of the new CPTSD diagnosis for ICD-11
title_full_unstemmed Development of the new CPTSD diagnosis for ICD-11
title_short Development of the new CPTSD diagnosis for ICD-11
title_sort development of the new cptsd diagnosis for icd-11
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919312/
https://www.ncbi.nlm.nih.gov/pubmed/33641675
http://dx.doi.org/10.1186/s40479-021-00148-8
work_keys_str_mv AT maerckerandreas developmentofthenewcptsddiagnosisforicd11